{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Aquebogue",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "83265",
      "recalling_firm": "Altaire Pharmaceuticals, Inc.",
      "address_1": "311 W Ln",
      "address_2": "PO Box 849",
      "postal_code": "11931-0849",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "U.S.A. Nationwide",
      "recall_number": "D-0354-2020",
      "product_description": "Perrigo Sterile Neo-Polycin HC (neomycin and polymixin B sulfates, bacitracin zinc and hydrocortisone acetate) Ophthalmic Ointment USP, Net Wt. 3.5 g  (1/8 oz), Rx only, Mfd. For Perrigo Minneapolis, MN 55427, NDC 0574-4144-35",
      "product_quantity": "87922 containers",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20190702",
      "center_classification_date": "20191115",
      "report_date": "20191127",
      "code_info": "Lot #: SEE, SEG, Exp 5/20; SIE, Exp 9/20; SKD, Exp 11/20"
    }
  ]
}